Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:13 pm Sale | 13G | ERASCA INC ERAS | ARCH Venture Fund X L.P. | 0 0.000% | -11,055,554 (Position Closed) | View |
| 2024-11-14 4:04 pm Sale | 13G | ERASCA INC ERAS | ARMISTICE CAPITAL LLC | 0 0.000% | -8,096,000 (Position Closed) | View |
| 2024-11-14 1:28 pm Purchase | 13G | ERASCA INC ERAS | T. Rowe Price Investment Management Inc. | 16,830,856 6.000% | 16,830,856 (New Position) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | ERASCA INC ERAS | BlackRock Inc. | 15,358,280 5.400% | 0 (Unchanged) | View |
| 2024-10-29 8:28 pm Purchase | 13G | ERASCA INC ERAS | City Hill LLC | 33,902,800 11.900% | 776,724 (+2.34%) | View |
| 2024-10-24 2:02 pm Purchase | 13G | ERASCA INC ERAS | BlackRock Inc. | 15,358,280 5.400% | 15,358,280 (New Position) | View |
| 2024-05-31 4:18 pm Purchase | 13G | ERASCA INC ERAS | Venrock Healthcare Capital Partners III L.P. | 16,216,216 6.500% | 16,216,216 (New Position) | View |
| 2024-05-29 11:55 am Purchase | 13G | ERASCA INC ERAS | Frazier Life Sciences Public Fund L.P. | 16,216,216 5.900% | 16,216,216 (New Position) | View |
| 2024-05-28 4:34 pm Purchase | 13G | ERASCA INC ERAS | SUVRETTA CAPITAL MANAGEMENT LLC | 13,768,039 5.500% | 13,768,039 (New Position) | View |
| 2024-02-14 3:36 pm Purchase | 13G | ERASCA INC ERAS | ARMISTICE CAPITAL LLC | 8,096,000 5.360% | 8,096,000 (New Position) | View |
| 2024-02-13 8:24 pm Purchase | 13G | ERASCA INC ERAS | City Hill LLC | 33,126,076 21.800% | 2,832,750 (+9.35%) | View |
| 2024-01-30 4:41 pm Sale | 13D | ERASCA INC ERAS | Cormorant Asset Management LP | 0 0.000% | -10,893,107 (Position Closed) | View |
| 2023-03-10 09:30 am Sale | 13G | ERASCA INC ERAS | FMR LLC | 1,078,970 0.783% | -8,358,274 (-88.57%) | View |
| 2023-02-14 4:20 pm Sale | 13G | ERASCA INC ERAS | City Hill LLC | 30,293,326 24.700% | -1,762,256 (-5.50%) | View |
| 2023-02-14 4:06 pm Sale | 13G | ERASCA INC ERAS | PFM Health Sciences LP | 4,797,460 3.200% | -2,953,028 (-38.10%) | View |
| 2023-02-09 10:59 am Sale | 13G | ERASCA INC ERAS | FMR LLC | 9,437,244 6.853% | -3,584,706 (-27.53%) | View |
| 2022-12-21 4:32 pm Purchase | 13D | ERASCA INC ERAS | Cormorant Asset Management LP | 10,893,107 7.260% | 387,554 (+3.69%) | View |
| 2022-12-19 4:21 pm Purchase | 13G | ERASCA INC ERAS | NOVARTIS PHARMA AG | 12,307,692 8.200% | 12,307,692 (New Position) | View |
| 2022-09-06 4:02 pm Purchase | 13G | ERASCA INC ERAS | PFM Health Sciences LP | 7,750,488 6.300% | 7,750,488 (New Position) | View |
| 2022-03-18 5:01 pm Purchase | 13G | ERASCA INC ERAS | Colt Ventures Ltd. | 6,488,040 5.351% | 6,488,040 (New Position) | View |